According to TransMedics Group's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 15.989. At the end of 2023 the company had a P/S ratio of 10.7.
Year | P/S ratio | Change |
---|---|---|
2023 | 10.7 | -49.41% |
2022 | 21.1 | 19.92% |
2021 | 17.6 | -16.6% |
2020 | 21.1 | 23.68% |
2019 | 17.0 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
PAVmed
PAVM | 8.64 | -45.96% | ๐บ๐ธ USA |
Philips PHG | 1.27 | -92.08% | ๐ณ๐ฑ Netherlands |